Скачать с ютуб #S2E6 в хорошем качестве

#S2E6

🧪🏭 Dive deep into the evolving world of the chemical industry with Maulik Patel, Managing Director of Epigral, in our latest podcast episode. Witness how Epigral has transformed from a subsidiary of Meghmani Organics to a standalone powerhouse, boosting its revenue from 830 crores in 2021 to 2188 crores in 2023, while significantly reducing dependency on chemical imports from China. In this episode, we explore: 1.⁠ ⁠Strategic Growth: Understand how Epigral has expanded to become India’s largest CPVC Resin producer with a capacity of 75,000 TPA. 2.⁠ ⁠Innovative Milestones: Discover the pioneering efforts behind establishing India’s first Epichlorohydrin plant and Chlorotoluene and value chain plant. 3.⁠ ⁠Reducing Imports: Learn about how Epigral’s strategic advancements are directly impacting and decreasing India’s reliance on chemical imports from China, fostering a more self-reliant industrial environment. 4.⁠ ⁠Visionary Leadership: Maulik Patel shares insights into the journey of navigating Epigral through immense growth and the strategies for future expansions. This episode offers a unique look at how a leader in the chemical industry is not just reacting to market demands but actively shaping the future of chemicals in India and beyond. It’s a must-watch for anyone interested in industrial innovation, business strategy, and leadership in high-stakes environments. 👉 Join us to explore how Epigral is setting the benchmarks in the chemical sector and what’s next for this dynamic company. Don’t forget to like, comment, and subscribe for more insightful content! #GreenSharks Season 2 0:00 Introduction 1:53 Promoter's Journey 4:50 Chemical Industry from Basics 6:00 What is the fuss about specialty chemicals 8:08 Understanding Meghmani Group 10:26 Biggest Constraint while doing Caustic Soda 12:28 Everything about Epichlorohydrin (ECH) 13:14 How did the demerger add value 16:28 The new ECH plant by Epigral 17:16 Uses of ECH 20:15 Backward Integration 23:49 Anti Dumping duty on ECH 27:20 Understanding CPVC 35:48 Approvals from new players 39:11 Understanding Chlorotoluene 43:37 How is it replacing Chinese Imports 47:47 Sectors that the company is exposed to 49:45 Raw Materials 56:56 Interesting Insights 59:05 2018- Response to Investor Concerns CORRECTIONS: 9:54- *Separate 14:46- *Brine Disclaimer- The data contained in the video is for educational purposes. We are neither responsible for any transactions nor investments conducted privately by the recipient, based on the above data. All investment decisions must be conducted with due diligence and after seeking advice. Read Full Disclaimer- https://drive.google.com/drive/u/1/fo... Additional Disclosure- 1.We are Green Portfolio, SEBI Registered Research Analyst vide Registration No.: INH100008513 & SEBI Registered Portfolio Managers vide Registration No.: INP000006022. 2. We have following financial interest in the company at the time of taking this interview: We have a 0.32% holding in the special fund 3. The interviewer does not hold any shares of Epigral.